Major Probable

Description

Quetiapine substantially potentiates oxycodone-induced CNS and respiratory depression, and both drugs prolong the QT interval.

Mécanisme

Quetiapine's CNS depressant and QT-prolonging properties combine with oxycodone's opioid-receptor-mediated CNS and respiratory depression.

Signification clinique

The combination is implicated in multiple fatal overdose cases and carries dual CNS depression and arrhythmia risk.

Prise en charge

Avoid combination; if unavoidable, use minimum effective doses, monitor ECG and respiratory status, and prescribe naloxone.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.